Life Expectancy Increased From 2022 to 2023, Reaching 78.4 Years
By Elana Gotkine HealthDay Reporter
THURSDAY, Dec. 19, 2024 -- Life expectancy in the United States increased in 2023, reaching 78.4 years, while drug overdose mortality decreased from 2022 to 2023, according to two December data briefs published by the National Center for Health Statistics.
Sherry L. Murphy, from the National Center for Health Statistics in Hyattsville, Maryland, and colleagues used data from the National Vital Statistics System to examine mortality patterns in the United States. The researchers found that from 2022 to 2023, there was an increase of 0.9 years in life expectancy for the U.S. population, reaching 78.4 years in 2023. The age-adjusted death rate decreased 6.0 percent, from 798.8 to 750.5 deaths per 100,000 standard population from 2022 to 2023. For all age groups 5 years and older, age-specific deaths rates decreased from 2022 to 2023.
Matthew F. Garnett, M.P.H., and Arialdi M. Miniño, M.P.H., also from the National Center for Health Statistics, present the rates of drug overdose deaths from the National Vital Statistics System over 20 years, focusing on changes from 2022 to 2023. The researchers found that from 2003 to 2022, there was an increase in the age-adjusted rate of drug overdose deaths, from 8.9 to 32.6 per 100,000 standard population, but the rate decreased to 31.3 in 2023. From 2022 to 2023, rates decreased for people aged 15 to 54 years and increased for those aged 55 years and older; rates decreased for White non-Hispanic people and remained the same or increased for other race and Hispanic origin groups.
"The age-adjusted rate for drug overdose deaths involving synthetic opioids other than methadone decreased from 2022 to 2023, the first such decrease since the large increases that began in 2013," Garnett and Miniño write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-12-20 06:00
Read more
- Applied Therapeutics Receives Complete Response Letter from U.S. FDA Regarding New Drug Application for Govorestat for Classic Galactosemia
- U.S. Food and Drug Administration Issues Complete Response Letter for the Glepaglutide New Drug Application for the Treatment of Short Bowel Syndrome
- Deep Belly Fat May Help Spur Alzheimer's Decades Before Symptoms Begin
- Twice-Yearly Injection 96% Effective in Preventing HIV Infection
- Stroke Survivors Face Much Higher Odds for Dementia
- Newer Drug Could Be Advance Against Tough-to-Treat Breast Cancers
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions